Buy & Sell Vanguard Total Stock Market Index Fund ETF (VTI) – Vanguard Total Stock Market Index Fund ETF Price Today
Aura AI Summary
Key Stats
- -Market Cap
- -Sector
- -6.77%3M Drawdown
- -Enterprise Value
- -Dividend Yield
- 65% Buy | 35% SellTrading Activity
- 119 daysTypical Hold Time
Over the past 52 weeks, Vanguard Total Stock Market Index Fund ETF has traded between a low of $291.72 and a high of $374.36, highlighting its annual price range. Over the past three months, Vanguard Total Stock Market Index Fund ETF has recorded a drawdown of -6.77%, reflecting recent price volatility. On average, investors hold Vanguard Total Stock Market Index Fund ETF for approximately 119 days, indicating typical investor behavior on the platform.
About Vanguard Total Stock Market Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the index, which represents approximately 100% of the investable US stock market and includes large-, mid-, small-, and micro-cap stocks. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
Most Recent News
CN partners with BHP to transport potash from Saskatchewan's Jansen Mine to global markets via rail.
Canadian National Railway Company (CN) has signed an agreement with BHP to transport potash from the Jansen Potash Mine in Saskatchewan to export terminals on Canada's West Coast. This rail service will connect one of the world's largest new potash d...

CN partners with BHP to transport potash from Jansen mine to global markets via Canadian west coast ports
Canadian National Railway (CN) has signed a transport agreement with BHP to support the shipment of potash from the Jansen mine in Saskatchewan to export terminals on Canada's west coast. This partnership leverages CN's extensive rail network to conn...

Judge rules Abbott's PediaSure marketing may mislead consumers about height growth claims
A U.S. federal judge ruled that Abbott Laboratories' marketing of PediaSure could reasonably be interpreted as promising height growth, despite the company's claims focusing on general growth. The judge noted product packaging and advertising featuri...
